Has Savyasachi Thakkar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $216,077 in general payments to Savyasachi Thakkar, MD across 173 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Savyasachi Thakkar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Savyasachi Thakkar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Savyasachi Thakkar, MD

Orthopaedic Surgery · Washington, DCNPI 1952626335

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $134,373 of the $216,077 with a category attached, or 62.2%. Medical Device Business Services, Inc. accounts for 75.1% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $102,161, more than ten times the $3,270 reported in 2019. Among orthopaedic surgery clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$216,077in general payments, 2019–2025

Across 173 payments — averaging $1249.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$162K
Smith+Nephew$28K
Johnson & Johnson$12K
Depuy Synthes Products, Inc.$10K
Zimmer Biomet$1K
KCI USA, Inc.$947
plus $2K from 9 others

$29,825in research payments, 2019–2025

Across 6 payments — averaging $4970.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$30K

What the payments were for

Consulting fees$134,37362%
Speaking & faculty fees$62,50029%
Travel & lodging$11,8155%
Food & beverage$6,7303%
Education$6600%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	83	$162,313
Smith+Nephew	27	$28,019
Johnson & Johnson	26	$11,559
Depuy Synthes Products, Inc.	10	$9,954
Zimmer Biomet	8	$1,297
KCI USA, Inc.	5	$947
Supreme Orthopedic Systems, LLC	2	$677
Hikma Pharmaceuticals USA	1	$344
Brainlab, Inc.	1	$213
Globus Medical	1	$195
Baxter Healthcare	3	$148
Encore Medical, LP	1	$144
Stryker	3	$129
Medacta USA, Inc.	1	$91
Tactile Systems Technology Inc	1	$48

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$216,077 in reported general payments places this provider in the 90th percentile of 46 orthopaedic surgery providers in District of Columbia.

See all orthopaedic surgery providers in District of Columbia →

Medicare billing

Part B allowed, 2024

$402,511

Medicare patients

709

Services billed

2,331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	74	$2,266
Celecoxib	47	$1,244
Mupirocin	114	$762
Meloxicam	90	$314
Cyclobenzaprine Hcl	15	$115
Oxycodone Hcl	14	$73
Methylprednisolone	14	$72
Amoxicillin	15	$55
Tramadol Hcl	14	$30

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Washington

Akhil KhannaWashington$2.1M
Seyed KalantarWashington$886K
Scott FaucettWashington$610K
David LuttonWashington$375K
Joseph FergusonWashington$84K
Robert SterlingWashington$38K
Ryan MurrayWashington$32K
Robert HenshawWashington$24K
Sandesh RaoWashington$21K
James DebritzWashington$14K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →